PROVIDER PROFILE · NPI 1043489271

Naomi Walinsky-King

Family PracticePhiladelphia, PAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,755

Beneficiaries

—

Total drug cost

$162K

Distinct drugs

Brand share

21.7%

Top prescribed drugs

Atorvastatin Calcium193 claims

Albuterol Sulfate99 claims

Amlodipine Besylate92 claims

Metformin Hcl80 claims

Gabapentin78 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Naomi Walinsky-King's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
DELAWARE VALLEY COMMUNITY HEALTH, INC.	44	74
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	18	33

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
DELAWARE VALLEY COMMUNITY HEALTH, INC.	121	255
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	34	86
TEMPLE UNIVERSITY HOSPITAL, INC	14	61

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history